Brain Multimodality Monitoring: Updated Perspectives

Area of Science:

• Neuroscience
• Critical Care Medicine
• Neurological Surgery

Background:

• Acute brain injury (ABI) management faces challenges from secondary brain injury (SBI) due to inflammation, edema, and ischemia.
• Secondary brain injury (SBI) can be subclinical but is detectable through physiological changes.
• Monitoring parameters like intracranial pressure (ICP), cerebral blood flow (CBF), and brain tissue oxygenation (PbtO2) can indicate tissue injury.

Purpose of the Study:

• To review current consensus guidelines on the utilization of multimodality monitoring (MMM) for acute brain injury.
• To examine recent evidence supporting the use of MMM in detecting and managing secondary brain injury.
• To discuss future directions and emerging questions regarding the application of MMM.

Main Methods:

• Review of existing literature and consensus guidelines on multimodality monitoring (MMM).
• Analysis of physiological parameters measured by neurological monitors, including ICP, CBF, PbtO2, cerebral metabolism, and electrocortical activity.
• Integration of neurological monitoring with hemodynamic monitoring and physical examination.

Main Results:

• Multimodality monitoring (MMM) integrates diverse physiological data to provide a comprehensive view of brain status.
• Physiological changes detected by MMM serve as surrogates for tissue injury and can guide interventions.
• Current guidelines exist for MMM, with ongoing advancements and research.

Conclusions:

• Multimodality monitoring (MMM) is crucial for detecting and managing secondary brain injury (SBI) following acute brain injury (ABI).
• The integration of various monitoring parameters aids clinicians in intervening before irreversible damage occurs.
• Continued research and adherence to guidelines are essential for optimizing MMM use.